About Axenis
Axenis is a company based in Paris (France) founded in 2010 was acquired by GenOway in September 2018.. Axenis operates in a competitive market with competitors including Biocytogen, Interius Biotherapeutics, Applied StemCell, GenOway and Nagi Bioscience, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
European Commission
& 2 more
-
Employee Count
Employee Count
-
Acquired by
GenOway
(Sep 04, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Axenis
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(31 Oct 2015)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Grant - Axenis | Valuation |
investors |
|
| Oct, 2015 | Amount | Grant - Axenis | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Axenis
Axenis has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Commission, GenOway and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Institution of the European Union responsible for upholding the EU treaties
|
Founded Year | Domain | Location | |
|
Provider of transgenic rodent models and customized cell lines for preclinical development
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Axenis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Axenis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Axenis Comparisons
Competitors of Axenis
Axenis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Interius Biotherapeutics, Applied StemCell, GenOway and Nagi Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating multiple diseases
|
|
| domain | founded_year | HQ Location |
Provider of animal and cell line models as tools for drug discovery and diagnostics
|
|
| domain | founded_year | HQ Location |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| domain | founded_year | HQ Location |
Developer of a organism on a chip based technology
|
|
| domain | founded_year | HQ Location |
Humanized models and drug screening technologies are developed for research.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Axenis
Frequently Asked Questions about Axenis
When was Axenis founded?
Axenis was founded in 2010 and raised its 1st funding round 5 years after it was founded.
Where is Axenis located?
Axenis is headquartered in Paris, France.
What does Axenis do?
Axenis was founded in 2010 in Paris, France, within the biotechnology sector. Immunocompromised mice, lacking T-cells, B-cells, and NK cells through Rag2-- and IL-2R-- modifications, are grafted with human blood cells to create the BRGS HIS model. This humanized immune system is applied in studies of immunology, inflammation, infectious diseases, vaccine and drug screening, oncology, stem cell transplantation, gene therapy, and personalized medicine.
Who are the top competitors of Axenis?
Axenis's top competitors include Biocytogen, Applied StemCell and GenOway.
Who are Axenis's investors?
Axenis has 3 investors. Key investors include European Commission, GenOway, and EIC Fund.